TuHURA Biosciences Files 8-K on Operations
Ticker: HURA · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1498382
Sentiment: neutral
Topics: 8-K, financial-condition, operations
TL;DR
TuHURA Biosciences (fka Kintara) filed an 8-K on April 1st detailing its financial condition.
AI Summary
TuHURA Biosciences, Inc. (formerly Kintara Therapeutics, Inc.) filed an 8-K on April 1, 2025, reporting on its results of operations and financial condition. The filing indicates the company is incorporated in Nevada and its fiscal year ends on December 31st. TuHURA Biosciences is involved in the Pharmaceutical Preparations industry.
Why It Matters
This 8-K filing provides an update on TuHURA Biosciences' operational and financial status, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting operational and financial information, not indicating any immediate significant risks or events.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- TuHURA Biosciences, Inc. (company) — Registrant
- Kintara Therapeutics, Inc. (company) — Former company name
- DelMar Pharmaceuticals, Inc. (company) — Former company name
- Berry Only Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- April 1, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for TuHURA Biosciences, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
What was TuHURA Biosciences, Inc. formerly known as?
TuHURA Biosciences, Inc. was formerly known as Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., and Berry Only Inc.
In which U.S. state is TuHURA Biosciences, Inc. incorporated?
TuHURA Biosciences, Inc. is incorporated in Nevada.
What is the Standard Industrial Classification (SIC) code for TuHURA Biosciences, Inc.?
The SIC code for TuHURA Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
On what date was this 8-K filing made?
This 8-K filing was made on April 1, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).